BioPlus Acquisition Corp. (BIOS)
BIOSPrice: $10.79
Fair Value: 🔒
🔒score
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and ... more
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share... more
Description
Shares
| Market Cap | $209.07M | Exchange | NASDAQ |
| Sector | Financial Services | Industry | Shell Companies |
| Country | US | CEO | R. Ross Haghighat |
| IPO Date | 2022-01-28 | CAGR | — |
| Employees | — | Website | bioplusspac.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.05% | Total Yield | 0.05% |
BIOS chart loading...
Fundamentals
Technicals
| Enterprise Value | $265.98M | P/E Ratio | 51.4 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | 28.94 |
| P/CF Ratio | -9332.6 | P/FCF Ratio | -302.36 |
| EPS | $0.21 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | — | Gross Margin | — |
| Operating Margin | — | Profit Margin | — |
| ROE | 0.02% | ROA | 0.02% |
| ROCE | -0% | Current Ratio | 1.04 |
| Quick Ratio | 1.04 | Cash Ratio | 0.27 |
| Debt/Equity | 0.02 | Interest Coverage | — |
| Altman Z Score | 7.23 | Piotroski Score | 2 |